Spots Global Cancer Trial Database for refractory myasthenia gravis
Every month we try and update this database with for refractory myasthenia gravis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis | NCT00424489 | Myasthenia Grav... | Hematopoietic S... Cyclophosphamid... ATG (rabbit) Mesna Methylprednisol... G-CSF | 15 Years - 65 Years | Northwestern University | |
A Pilot Trial of Rituxan in Refractory Myasthenia Gravis | NCT00619671 | Refractory Myas... | Rituximab (Ritu... | 18 Years - 80 Years | University of Vermont | |
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis | NCT00424489 | Myasthenia Grav... | Hematopoietic S... Cyclophosphamid... ATG (rabbit) Mesna Methylprednisol... G-CSF | 15 Years - 65 Years | Northwestern University | |
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis | NCT00424489 | Myasthenia Grav... | Hematopoietic S... Cyclophosphamid... ATG (rabbit) Mesna Methylprednisol... G-CSF | 15 Years - 65 Years | Northwestern University |